Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease
Objective. The aim of the present study was to investigate whether pentraxin 3 (PTX3) can be a new noninvasive marker for prediction of liver fibrosis in patients with NAFLD. We also aimed to evaluate the relationship between PTX3 and atherosclerosis in patients with NAFLD. Method. Fifty-four male p...
Main Authors: | Kadir Ozturk, Omer Kurt, Tolga Dogan, Alptug Ozen, Hakan Demirci, Fatih Yesildal, Murat Kantarcioglu, Turker Turker, Ahmet Kerem Guler, Yıldırım Karslioglu, Battal Altun, Ahmet Uygun, Sait Bagci |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/1417962 |
Similar Items
-
Geopolitics of Caspian Oil and Gas
by: Ahmet Tolga Turker
Published: (2012-01-01) -
Nationalism and Modernization: A Comparative Case Study of Scots and Kurds
by: Turker, Ahmet Tolga
Published: (2008) -
Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01) -
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease
by: Halil Genc, et al.
Published: (2013-07-01) -
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
by: Saito Satoru, et al.
Published: (2008-11-01)